RankingsPricing
  1. US-listed companies
  2. Edwards Lifesciences Corp
  3. Financials
  4. Gross margin (%)

Edwards Lifesciences CorpEW

Market cap
$49.9B
P/E ratio
SummaryFinancials
Period EndGross margin (%) YoY (%)
Dec 31, 202479.5+3.16%
Dec 31, 202377-3.64%
Dec 31, 202279.9+4.99%
Dec 31, 202176.1+1.02%
Dec 31, 202075.4+1.34%
Dec 31, 201974.4-0.53%
Dec 31, 201874.8+0.33%
Dec 31, 201774.5+1.95%
Dec 31, 201673.1-2.86%
Dec 31, 201575.2+2.99%
Dec 31, 201473.1-1.87%
Dec 31, 201374.5+0.67%
Dec 31, 201274+4.44%
Dec 31, 201170.8-1.34%
Dec 31, 201071.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)